List Of China API Manufacturers

A

Apeloa

Apeloa came out of the Hengdian Group back in 1989. They’re based in Dongyang City, Zhejiang, and they now have about 7,400 people on staff. The company runs eight plants and three R&D labs in Hengdian, Shanghai, and Boston. In 2024 they pulled in around $1.2 billion. They make the raw drug stuff that goes into heart pills, germ fighters, mood drugs, and cancer drugs.

Here’s what makes them stand out. They run five plants for chemical work and two for making things by growing bugs in tanks. The FDA has checked them out twenty times since 2006, and four of those checks came in just the last two years. All clean. No issues found. Their contract work arm teams up with big global drug firms, and they’ve put over $20 million into flow chemistry tech in the past ten years. Back in 2022, they were one of five Chinese firms picked to make Pfizer’s oral COVID pill for poorer nations.

They spend more than five cents of every dollar they earn on R&D. Over 1,300 lab folks work there. They also have ties with top schools like Shanghai Jiao Tong and Zhejiang U. Their game plan rests on four things: lead the world in bulk drug stuff, nail the contract work game, sell cheap good drugs, and grow their beauty and care line.

Asymchem

Asymchem runs out of Tianjin and has made a name doing tricky chemistry work that other shops can’t pull off. They do it all, from early lab work to large batch runs. Some of the biggest drug firms on earth trust them with hard jobs.

The FDA has looked over their plants and given the nod. They’ve grown fast by putting money into both gear and brain power, and their knack for solving tough problems keeps the work flowing in.

Aurisco

Aurisco is a niche player that goes after tough, strong, and tightly watched drug raw goods. Think hormone drugs and things the law keeps close tabs on. That kind of work needs special gear and very strict rules.

Their plants have passed checks from agencies in many lands. They serve drug firms in China and abroad with both custom jobs and large batch work. Not a huge name, but they fill a gap that most firms can’t or won’t touch.

B

Bloomage Biotech

Bloomage set up shop in Jinan, Shandong around the year 2000 and has since become one of the world’s top makers of HA, a thing used in eye drops, joint shots, and wound care goods. They trade on the Shenzhen stock market now.

Tank growing tech sits at the core of what they do, and they’ve scaled it up to a massive level. Their stuff ships to more than 100 lands.

They’ve also pushed into other bio-based drug raw goods beyond HA, which shows they don’t want to be a one-trick shop. Research hubs in more than one Chinese city drive new product work.

Boai NKY

Boai NKY works out of Henan and has carved out a spot as one of China’s top makers of PEG. That stuff shows up in all kinds of drug blends, body care items, and factory goods. It’s not flashy work, but it matters a lot.

They’ve built their chain from basic chemicals all the way up to drug-grade end goods. Lots of global certs back up their quality claims, and sales in Asia, Europe, and the Americas keep climbing year after year.

Brother Enterprises

Brother holds a spot in Zhejiang and has become one of China’s bigger vitamin makers. Vitamin E, vitamin A, and other health raw goods pour out of their big plants to buyers all over the world.

They got going in the early 2000s and grew by betting hard on tank growing and chemical tech. Their goods go toe to toe with top global brands on both price and quality. Drug firms, food firms, and animal feed firms all buy from them. They’ve also moved into fine chemicals, which rounds out the revenue base.

C

CSPC Group

CSPC, or Shijiazhuang Drug Group as some call it, has been on the Hong Kong stock market since 1994. They’re based in Hebei and bring in close to 29 billion yuan a year. About 19,000 people work there. Their brand has been in the Top 500 Most Valued Brands in China for over ten straight years.

The bulk drugs side is where the raw drug stuff lives. Vitamin C is huge for them. One arm of the group, CSPC Weisheng, can make 50,000 tons a year from a plant that came up with its own “two-step” tank growing method. That same arm was the first vitamin raw goods maker in China to pass the German GMP check back in 2008. Germ killers and caffeine round out the bulk line, which pulled in about 3.6 billion yuan in 2024. Vitamin C sales alone hit 2.03 billion yuan.

But CSPC has been shifting gears. Finished drugs now bring in close to 80 percent of all money. Over 2,000 R&D folks work out of labs in four cities, including one in the US. They’ve built eight major R&D setups for things like nano drugs, mRNA, and cell work. By late 2024 they had filed over 2,200 patents and had close to 1,000 granted. A deal with AstraZeneca in mid-2025 came with $110 million up front and could be worth billions more down the road.

D

Dalian Chempharm

Dalian Chempharm sits in the northeast, in Liaoning. They make basic drug raw goods and middle stage chemicals.

Dalian’s port and strong chemical scene help keep costs down. They’re the kind of mid-size shop that doesn’t grab news but fills a key role in keeping the global supply of core drug raw goods steady.

Every supply chain needs firms like this. The big names get the press, but the Dalians of the world keep the gears turning day in, day out.

Dongying Tiandong

Dongying Tiandong is based in Shandong and makes germ fighter raw goods, mainly the kind used in pills and shots to treat bad bugs. They handle a few types of these drugs at plants that meet global GMP rules.

Shandong’s deep chemical base gives them easy access to what they need to keep costs low and output high. They’re not a household name, but the global germ fighter supply chain would feel the pinch if they went away.

F

Fosun Pharma

Fosun has been around since 1994, with Shanghai as home and yearly sales near $3.5 billion. Their raw drug goods span germ fighters, brain drugs, and sugar sickness drugs, among others. But what sets Fosun apart is how much they do. Health gear, testing tools, care clinics, and a long track of global deals all sit under the same roof.

Their tie-up with BioNTech for COVID shots in Greater China put them on the world stage in a big way. Many global joint deals and buys have pushed their reach well past China’s borders.

Raw drug goods stay a core cash source, with plants across the land feeding both their own drug lines and outside buyers all over the world.

Fujian South

Fujian South runs out of southeast China and sticks to germ killer raw goods, mainly the kinds used in shots and IV bags.

What sets them apart from a lot of rivals is their clean room setup for making shot-grade drug stuff. That’s a must for drugs that go right into your blood. Their plants have cleared checks from agencies in many lands, and they ship across Asia, Europe, and the US. It’s a niche, but an important one.

G

Guangji

Guangji works out of Wuxue City in Hubei. They’ve become one of China’s go-to makers of B vitamin raw goods, and their output of B2 puts them near the top in the world. They trade on the Shenzhen market.

They also make heart and brain drug stuff. Plants run both big tank growing lines and chemical setups. FDA sign-off is among their global certs. Goods ship to buyers in over 30 lands, which gives them a reach that goes well past China’s borders.

Guobang Group

Guobang got going in 1996 in Xinchang, Zhejiang. They cover raw drug goods, blended drugs, and middle stage chemicals, in both the human and animal health fields. The firm sits among China’s top 100 drug firms.

Zhejiang’s drug making hub gives them access to skilled workers and a strong supply base. Export trade has grown steadily as global buyers seek out solid Chinese drug stuff partners. Their full spread of goods, from raw to finished, gives them flex that pure raw goods shops don’t have.

H

Hangzhou Jiuyuan

Jiuyuan stands out from most firms on this list because they use biotech methods rather than plain old chemistry. Working out of Hangzhou, they make things like man-made human proteins used in shots and other drugs.

Their R&D team works with labs both in China and abroad. Tight quality checks from start to finish have helped them win trust from buyers at home and overseas. As more bio drugs hit the market, firms like Jiuyuan are set to grow.

Harbin Group

Harbin Group is one of the oldest drug firms in China, going back to the 1940s up in the cold north. It’s a huge outfit that spans raw drug goods, finished drugs, and Chinese herb meds.

Drug stuff output covers germ fighters, heart drugs, and more. Brand power at home is massive. Their size gives them real buying clout for raw goods and keeps costs in check.

Goods reach markets across China and in dozens of lands abroad. Few firms in the country can match their name pull or their scale of work.

Hebei Jiheng

If you pop a pain pill or cold tab just about anywhere on earth, there’s a real chance the main stuff in it came from Jiheng. They’re one of China’s top makers of the raw form of what most of us call Tylenol.

They also turn out caffeine and other bulk drug goods at truly massive scale. Output runs into tens of thousands of tons a year. Their Hebei plants ship to drug firms in dozens of lands.

Full in-house chemical chains keep costs tight in a market where every tiny price edge counts. Jiheng isn’t a company that shows up in the news much, but take them out of the picture and a lot of medicine cabinets around the world would feel it.

Hubei Gedian Humanwell

Humanwell sits in Ezhou, Hubei, and is part of the wider Humanwell Health Group. They were set up in 2000 and run two raw drug plants, a drug blend plant, and a filler plant with about 900 workers.

Hormone drugs, brain drugs, and virus fighters are the main lines. They’ve built a full chain from pulling out raw goods to making and packing the end drug stuff. They rank as one of China’s key makers of a few important raw drugs in the hormone space.

Over 20 years of know-how in this area has opened doors to working with major global drug firms. Goods ship to more than 150 lands, with strong reach in North and South America, Europe, and Africa.

J

Jiangsu Hansoh

Hansoh is one of the faster growing new-style drug firms in China, based in Jiangsu. They’re known mainly for finished drugs, but their raw drug goods arm is big in its own right.

It feeds cancer drugs, brain drugs, and germ fighters both in-house and to outside buyers. Their Hong Kong listing in 2019 raised their global profile a lot. R&D spend as a share of sales ranks among the highest of any Chinese drug firm, and full control from raw goods through to final pills and shots gives them cost and quality edges that are hard to beat.

Jiangsu Hengrui

Hengrui comes up in just about any talk on Chinese drug making. The firm goes back to 1970 and has grown into a real force, pulling in around $2.5 billion a year. Cancer drug raw goods and middle stage goods sit at the core of their work, but they also make stuff for sleep drugs used in surgery and contrast dyes.

Their setup runs from raw drug stuff all the way to finished drugs. FDA and EMA checks have cleared the path for sales in Western markets.

Thousands of lab folks work on new drug ideas, and the firm’s listing on the Shanghai stock market makes it one of the most valued drug firms in the land. Their raw goods arm serves both in-house needs and outside drug makers looking for top-notch stuff.

Jiangsu Nhwa

Nhwa has a focus that not every shop can handle: sleep and brain drug raw goods. Based in Jiangsu, they’ve become one of China’s top sources for the kinds of tightly watched drug stuff used in surgery and pain care.

Making these goods takes special gear and very strict rule sets. Nhwa has built the right setup to do it well. Their home market share in this space ranks among the highest in the land, and that kind of grip is tough to loosen.

L

Livzon Group

Livzon got started in 1985 in Zhuhai, way down in southern China’s Guangdong. They’ve since grown into a big drug group with yearly sales near a billion bucks and over 8,000 workers.

Their raw drug goods arm leans toward biotech and hormone drugs, covering health areas like having babies, hormone balance, and fighting germs. What makes Livzon a bit different is their work with tiny sphere tech for slow-release drug delivery. That sets them apart from the run-of-the-mill raw goods shop.

They’ve mostly sold at home so far but are slowly building up filings and pushing into foreign markets.

Luye Pharma

Luye works out of Yantai, Shandong and trades in Hong Kong. Brain and cancer drugs drive the lineup.

Their raw drug making feeds into plants that do long-acting shots, skin patches, and other fancy delivery methods. Tiny sphere and fat bubble know-how gives them a real edge that’s tough for rivals to copy. They now have work going on in the US, Europe, and across Asia.

N

Ningbo Team Pharma

Ningbo Team Pharma works out of Zhejiang and has built a good name in germ killer raw goods. They run modern plants for both clean room and standard work.

Ningbo’s great port access and Zhejiang’s wider drug making scene give them clear edges in shipping and supply chains. Fair prices and on-time delivery have earned them spots on vendor lists of major global generic drug firms. That’s not easy to do, and it speaks to how they run things.

North China Pharma (NCPC)

NCPC is one of China’s oldest and largest raw drug goods makers. Based in Shijiazhuang, Hebei, the firm has been at it since the 1950s. The sheer scale of their work is hard to take in.

Germ killers are the crown jewels, but they also make vitamins, heart drugs, and cancer drug raw goods. Their chain runs from growing raw stuff all the way through to making finished drugs.

The Huasheng arm handles niche goods and holds global GMP certs. NCPC has put a lot of money into R&D and green upgrades as Chinese rule makers crack down on dirty air and water from drug plants. Their germ killer tech, built up in-house over many decades, gives them an edge that newer rivals find hard to match.

P

Porton Pharma

Porton runs contract work and raw drug goods making from sites across China. Custom work, process build-out, and large batch runs for drug firms the world over are all in the mix.

Tricky chemistry is what they do best: mirror image drugs, very strong compounds, and tightly watched goods. FDA-checked plants and global certs give them trust with Western buyers. Their tech in flow chemistry and enzyme-based methods sits at the cutting edge, and sales growth has been strong as more global drug firms look to farm out raw goods making to China.

Q

Qilu Pharma

Qilu does pretty much all of it: R&D, making, sales, and global trade of both raw drug goods and finished drugs. They’ve been based in Jinan, Shandong since 1958.

The germ killer raw goods arm alone is massive. Their sub-firm Qilu Antibiotics, set up in 1995, pumps out some of the largest batches in the land. Past germ killers, their raw goods line covers cancer, brain, heart, and blood sugar drugs. Goods sell in over 80 lands, backed by FDA and EMA filings. Many plants across Shandong run day and night.

The mix of scale, range, and quality makes Qilu one of China’s most vital raw drug goods sources. You’d be hard pressed to name a drug type they don’t touch in some way.

Their Shandong roots run deep, and the local talent pool of trained chemists and plant workers is one of the thickest in the country. That helps when you’re trying to keep dozens of product lines humming at the same time.

R

Reyoung

Reyoung works out of Shandong and has become a real force in Chinese raw drug goods making. Their line covers germ fighters, heart drugs, and blood sugar drugs.

Big plants and a focus on doing things well help them make goods at costs that put heat on rivals. Quality setups meet both Chinese and global GMP rules, and they ship to drug firms around the globe. Not the flashiest name on this list, but they get the job done at scale.

S

Sandoo

Sandoo was set up in 2009 and runs a raw drug goods and middle stage business that’s mostly about export. About 90 percent of what they make goes out of the land to more than 20 nations.

They use FDA-cleared and GMP-backed supply lines and have R&D hubs in Shanghai, Beijing, Guangzhou, and Hangzhou. Being so focused on exports means they get the paper work and rule sets that foreign buyers need. That edge matters more than you might think.

Shandong Buchang

Buchang is based in Shandong and makes a range of raw drug goods next to their well known Chinese herb and Western drug lines. Heart and brain drugs are big product groups.

They’ve grown into one of Shandong’s largest drug firms. China’s push to expand health care reach has helped drive sales growth, and they’ve ridden that wave well.

Shandong Chenlong

Chenlong focuses on germ killer raw goods making in Shandong. The core lines are raw goods and middle stage chemicals that feed into the global germ fighter supply chain.

GMP plants handle many product lines, and the firm’s spot within Shandong’s drug making cluster gives them access to raw stuff at good prices. They supply both Chinese and global generic drug makers with steady, no-fuss output.

Shandong Luoxin

Luoxin runs out of Linyi, Shandong and covers both raw drug goods making and finished drug output. Germ killers and heart drugs fill the product list.

They trade on the Shenzhen market and have grown through a mix of in-house growth and buy-outs. Their raw goods arm feeds both their own pill plants and outside drug firms.

Global rule filings are growing as the firm pushes harder into export markets. They want a bigger slice of the pie outside China, and they’re putting in the work to get it.

Shandong Xinhua

Xinhua goes all the way back to 1943. That makes them one of the oldest drug makers in China, period. Their Zibo City base in Shandong has been making raw drug goods for more than 80 years.

Pain drugs, fever drugs, and swelling fighters lead the list, but they also make heart and brain goods. They’ve teamed up with some of the top schools in the land, such as the Chinese Academy of Medical Sciences, Tsinghua, and Shandong U.

Six focused labs cover drug chemistry, drug blending, and other fields. Goods ship to rule-based markets all over the world, backed by global quality certs. Eight decades in the game counts for a lot.

Shanghai Pharma

Shanghai Pharma is one of China’s biggest drug groups, full stop. They cover everything from raw drug goods making through drug shipping and retail drug shops.

The raw goods arm makes stuff across germ fighter, heart, cancer, and other drug types. Scale is huge, with yearly sales near the very top of all Chinese drug firms. Supply webs stretch across the whole land, and raw goods exports feed drug makers in dozens of nations. It’s hard to overstate how large this outfit really is.

Shenzhen Haibin

Haibin is part of the JointCare group and does one thing really well: they make raw goods for a class of germ killers called carbapenems. If you know germ fighters at all, you know these are the heavy guns saved for the worst bugs.

The chemistry to make them is truly hard, which caps the number of firms that can do it well. That gives Haibin a natural shield against new rivals.

Rule nods from many lands back their global sales, and clinics around the world count on what flows out of their plants. When a patient has a bug that nothing else can kill, odds are decent the drug traces back to raw goods from a place like Haibin.

Shenzhen Hepalink

Hepalink’s story goes back to 1986. Over the decades they’ve grown into one of the world’s biggest makers of a blood thinning raw drug good called heparin. This stuff shows up in countless surgeries and steps all over the world. They’ve been making and studying it for more than 30 years.

Their Shenzhen plants run top-tier gear, and the firm trades on the Shenzhen market. The history here matters. More than three decades of heparin work gives them a depth of know-how that newer firms would need years to build up.

But Hepalink has grown well past basic raw goods supply. Through arms like Techdow Pharma, they now work in the US, UK, Poland, Italy, Spain, and Germany. New drugs in the works target cancers and heart disease. Still, heparin raw goods remain the bedrock that brings in billions and makes Hepalink a must-have link in the global drug supply chain.

Sichuan Kelun

Kelun is a big drug group based in Chengdu, Sichuan, with yearly sales north of 40 billion yuan. More than 100 firms at home and abroad fall under their wing.

Their line covers large batch IV bags, raw drug goods, and germ killers, plus a growing set of new drug ideas. IV fluid making alone makes them one of the largest in China. Lately Kelun has pivoted hard toward new drug R&D, mainly cancer and immune system drugs. Global deals and tie-ups have raised their name around the world. The pivot from volume goods to cutting-edge drug work is one of the bigger bets any Chinese drug firm has made in recent years.

Sichuan Xieli

Xieli works out of Sichuan and makes germ killer raw goods, mainly the types used in pills and shots to fight bad bugs.

They’re known as a solid source for drug makers at home and abroad. Low-cost making gives them strong standing in price-tight global germ fighter markets, and they’ve put money into better tech and greener work as Chinese rules get tighter.

Sino Biopharma

Sino Biopharma trades in Hong Kong and runs major work across mainland China. Yearly sales come close to $3 billion.

R&D sits at the core of what they do, with thousands of lab folks working on new drug ideas. Liver disease and cancer drug raw goods rank among their best lines. Growth has come from both in-house work and buy-outs.

They’ve built one of the largest drug R&D teams in China. A growing footprint across other Asian markets shows they’re not content to stay in just one place.

Sinopharm

Sinopharm is in a league of its own. Sales top $40 billion. The firm works right under the Chinese state’s asset watch group. Set up in 2003, it grew fast into a leader in bio drugs and health care work. Over 128,000 people work across the full drug supply chain.

Raw drug goods making is one piece of a truly vast machine. Output covers generic drug stuff and special bio goods. Their COVID shot work raised their global name a great deal.

State backing gives Sinopharm access to funds and scale that private firms just can’t touch. When people talk about the power of Chinese state drug firms, Sinopharm is usually the first name that comes up.

For any firm trying to do business in China’s drug market, dealing with Sinopharm at some level is almost a given. Their tentacles reach into nearly every corner of the health care system.

Starry Pharma

Starry started in 1997 in Xianju, Zhejiang and went on the Shanghai stock market in 2016. They focus on raw goods and middle stage chemicals, with a strong spot in contrast dye goods used in medical scans.

In fact, they’re one of the biggest firms in China for generic contrast dyes. One of their key items ranks at the top in the land for output size. They bought Zhejiang Taizhou Hisyn in 2018 to grow even more, and global sales have been rising as they file for rule nods in new markets.

Suzhou Lixin

Lixin works out of Jiangsu and makes germ killer raw goods. The types they focus on go into clinic-grade shot drugs for very bad bugs.

The chemistry is truly hard, and Lixin has built real skill in this space over time. Their spot in Jiangsu’s drug making zone gives them access to nearby supply firms and trained workers.

Quality setups back sales to rule-based markets in Europe, the Americas, and across Asia. They’re not trying to be everything to everyone. They picked a lane and they own it.

T

Tianyu

Tianyu was set up in 1993 in Taizhou, Zhejiang. They make high-end middle stage goods, niche raw drug stuff, and blended drugs. Over the years they’ve become a go-to source for raw goods used in long-term disease and cancer drugs.

Key items cover blood pressure, blood sugar, fat, clot, and breathing drugs. What Tianyu can do that not every raw goods shop can match is true start-to-finish service, from early clinical work all the way through large batch runs.

Both brand name and generic drug firms around the world use them. Thirty-plus years on the job and a prime Zhejiang spot give them solid ground to stand on. They don’t try to do everything, but what they do, they do right.

W

WuXi AppTec (WuXi STA)

WuXi AppTec is likely the best known Chinese drug services firm in the world. The WuXi STA arm handles raw drug goods and drug making. Based in Shanghai, they help drug firms from first lab tests all the way through large batch output. Nearly every major drug firm on the planet works with them in some way.

The numbers speak loud. In 2023 alone, WuXi STA worked on about 50 projects from early stage to market scale and turned out more than 15 metric tons of a type of raw drug good called peptides. A new plant in Taixing, Jiangsu tripled their output for these goods in early 2024.

WuXi has faced heat from US laws aimed at certain Chinese biotech firms. But their role in global drug making runs so deep that pulling away is nearly out of reach for most clients. As of late 2024, only about 2 percent of drug firms that said they wanted to shift away had actually done so, even though 26 percent had voiced that goal. That gap between talk and action tells you everything about how tied in WuXi really is.

Y

Yantai Dongcheng

Dongcheng started in 1998 and went on the Shenzhen market in 2012. Based in Yantai, Shandong, they’ve grown into a big group that covers bio raw goods, chemical drugs, Chinese herb drugs, and nuclear imaging drugs.

Core items like sodium heparin and a joint health raw good have earned many global quality nods. These bio raw goods feed makers of blood thinning and joint care drugs around the world. The nuclear imaging side of the business gives them a foot in a space that most drug firms never even think about.

Z

Zhejiang Aoxiang

Aoxiang was set up in 2010 and listed in Shanghai in 2017. They’re young next to most names on this list, but they’ve made a quick mark in the raw goods and middle stage space from their Zhejiang base.

Being on the stock market gives them cash for growth and tech upgrades. The wider Zhejiang drug making scene offers deep know-how and strong supply lines all around them. Youth can be a plus in this trade when it comes with fresh thinking and fast moves.

Zhejiang Hisun

Hisun goes back to 1956 and has grown into one of the largest raw drug goods makers in all of China. Based in Taizhou, Zhejiang, more than 7,000 people work there. Total assets have hit 20 billion yuan with yearly sales past 10 billion yuan. Goods span more than ten health areas, from cancer and germ fighting to heart, hormone, immune, mood, and bone drugs.

Hisun began as a chemical firm and moved into drugs in the early 1970s. Since then they’ve taken on 47 major state drug R&D projects, won two state tech prizes, and filed for over 1,000 patents.

Global ties with well-known drug firms push their reach well past China. They’ve also built plants for a newer type of cancer drug and bio-similar goods, which shows they’re moving past old-school chemical raw goods. Hisun USA, set up in 2009, drives their push into the US market. During COVID, the firm got special praise from China’s State Council for their work in the fight against the outbreak.

Zhejiang Huahai

Huahai was set up in 1989 in Linhai City, Taizhou, Zhejiang. Close to 7,000 people work across more than 40 branches spread around the world, with work in the US, Japan, Germany, Russia, Spain, and India.

The firm shows what some call the model for a modern Chinese drug giant. They control everything from early stage raw stuff through drug making to final pill and shot output for export. Over 50 US Drug Master Files sit in their rule books. Main areas include heart, brain, and virus fighting drugs.

Huahai made global news when a likely cancer-causing thing was found in one of their key raw goods. The fallout was big, but they stood up, took the hit, and put heavy money into fixing things rather than hiding. Those who watch the trade have noted that Huahai is just too woven into the global chain to easily swap out.

Zhejiang Jiuzhou

Jiuzhou traces its roots to a small chemical plant in 1973. It became what it is now in 1998 and went on the Shanghai stock market in 2014.

Key items include a few well-known drugs for fits, gut swelling, joint pain, and blood sugar that sell all over the world. Their contract work client list is strong and includes names like Novartis, Roche, Zoetis, and Daiichi Sankyo. They also team up with top Chinese firms like HUTCHMED and Betta. End-to-end service from early lab work through large batch making rounds it out.

Zhejiang Langhua

Langhua works out of Zhejiang and focuses on heart and blood sugar drug raw goods. One key class of blood pressure drug stuff has become a main line feeding generic drug makers around the globe.

GMP plants and strong paper work meet the filing needs of US, European, and other major rule bodies. Steady quality at fair prices has kept them in the game in a very tough market where margins are thin and buyers are picky.

Zhejiang Medicine

Zhejiang Medicine formed in 1997 when three firms merged: Zhejiang Xinchang, Zhejiang Xianju, and Zhejiang Pharma.

Based in Shaoxing, Zhejiang, the combined firm makes raw drug goods, blended drugs, human and animal health items, and middle stage chemicals. Vitamin making is one of their best lines. More than 27 years in the game and a prime spot in China’s drug making belt give them edges in both home and global sales.

Zhejiang NHU

NHU was set up in 1999, went public in 2004, and works out of Xinchang, Zhejiang. They make raw drug goods like two common pain and germ fighting pills, plus vitamins and middle stage chemicals.

The firm calls itself a maker of useful chemicals, and its goals clearly go past the old bounds of the chemical trade. NHU ranks among the leaders in the Chinese raw drug goods market, and R&D money goes toward better items and greener ways to make them.

Home and global demand both keep growing. The mix of drug and health food raw goods gives them a spread-out income base that helps when one side has a slow year.

Zhejiang Ruibang

Ruibang is a Zhejiang-based maker of germ killer raw goods. They hold a solid mid-tier spot in China’s germ fighter supply chain.

Plants meet both Chinese and global GMP rules, and they’ve put money into better tech and greener work. Steady quality at fair prices keeps them on the cleared vendor lists of many global drug firms. Not every firm needs to be a giant to matter.

ZMC (Zhejiang Medicine Xinchang)

ZMC is part of Zhejiang Medicine’s Xinchang work. They focus on germ killer and vitamin raw goods. Key lines include certain types of germ fighter raw goods and middle stage chemicals.

Plants handle both tank growing and chemical work, with global GMP certs backing sales around the world. Their Xinchang spot puts them right in the thick of one of the densest clusters of drug makers in China, which gives them built-in perks when it comes to hiring and sourcing.

Zhuhai United Labs

Need the raw form of one of the world’s most used germ killers? Trade insiders will point you to Zhuhai United first. Based down in Zhuhai, Guangdong, they rank as one of China’s most key germ killer raw goods makers. The scale of their work in this space is hard to top.

The firm covers the full chain from growing germ killer base stuff in tanks through chemical tweaks to finished raw drug goods. Two of the most common germ killer types ship to drug firms across dozens of lands.

Output size gives them pricing power that few rivals can touch. Their Guangdong spot provides great shipping access for global trade, and they’ve put money into both growth and greener work to keep up with tighter rules.

When it comes to basic germ killer raw goods at scale, Zhuhai United is the name that keeps coming up. If global supply of these goods ever took a real hit, the effects would ripple out to clinics and drug shelves around the world pretty fast.